Melatonin for better sleep in the ICU
Treatments studied
This study tests whether giving melatonin, a natural sleep aid, can improve sleep quality for patients in the intensive care unit (ICU). If you are awake and can take medicine by mouth, this might help you rest better during your hospital stay.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently in the ICU and expected to stay for at least 48 hours
- You are not on a breathing machine (ventilator)
- You can take medications by mouth
- You are stable enough as determined by your ICU doctor
- You are not already taking melatonin before coming to the ICU
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a team of ICU doctors and nurses can work together to improve sleep for patients in the intensive care unit (ICU). The goal is to help patients rest better during their hospital stay.
This study tests whether a special sleep-promoting program can help patients in the intensive care unit (ICU) after surgery sleep better. If you or a loved one are recovering from surgery in the ICU, this program might improve sleep quality and recovery.
This study tests whether helping ICU patients sleep better and keeping their body clock on a normal day-night rhythm can improve recovery after surgery.
This study tests whether giving a medicine called dexmedetomidine (which helps people relax and sleep) as part of a sleep-promoting routine can reduce confusion and delirium in the intensive care unit (ICU). It may help you sleep better and recover more smoothly.
This study tests a “sleep chronobundle,” a set of sleep and light-timing steps, to improve daily sleep-wake timing in people in the ICU on breathing or blood-pressure support. It also checks whether the body’s sleep rhythms are more aligned during critical illness and over time.
This trial tests whether giving melatonin (or a placebo) can help adults in the intensive care unit who have a specific type of confusion called low-activity delirium. It aims to improve recovery by supporting sleep–wake regulation in the ICU.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.